Tai‐Juan Aw

526 total citations
7 papers, 384 citations indexed

About

Tai‐Juan Aw is a scholar working on Pharmacology, Biochemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tai‐Juan Aw has authored 7 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Biochemistry and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tai‐Juan Aw's work include Inflammatory mediators and NSAID effects (5 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Hormonal Regulation and Hypertension (4 papers). Tai‐Juan Aw is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Hormonal Regulation and Hypertension (4 papers). Tai‐Juan Aw collaborates with scholars based in Australia, Singapore and United States. Tai‐Juan Aw's co-authors include Danny Liew, Steven Joseph Haas, Henry Krum, Henry Krum, Christopher M. Reid, Clara C. Chan, Geoffrey H. Tofler, Hans G. Schneider, Baki Billah and Marie‐Christine Morel‐Kopp and has published in prestigious journals such as The Journal of Physiology, Journal of Hypertension and Journal of Cardiovascular Pharmacology.

In The Last Decade

Tai‐Juan Aw

7 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tai‐Juan Aw Australia 5 277 170 99 49 40 7 384
Julien Rossat Switzerland 6 201 0.7× 143 0.8× 99 1.0× 80 1.6× 17 0.4× 7 372
Peggy Wong United States 10 283 1.0× 108 0.6× 65 0.7× 18 0.4× 20 0.5× 21 415
Qinfen Yu United States 10 410 1.5× 152 0.9× 58 0.6× 96 2.0× 52 1.3× 11 665
Gabriele Merciaro Italy 6 382 1.4× 340 2.0× 79 0.8× 11 0.2× 25 0.6× 6 561
Anne-Marie Schjerning Denmark 10 95 0.3× 243 1.4× 16 0.2× 27 0.6× 35 0.9× 17 504
Vashu Thakur United States 13 73 0.3× 118 0.7× 28 0.3× 85 1.7× 18 0.5× 22 523
Ram V. Patak United States 10 242 0.9× 106 0.6× 161 1.6× 84 1.7× 9 0.2× 14 601
Rosamaria Tommasoli Italy 8 86 0.3× 165 1.0× 117 1.2× 34 0.7× 9 0.2× 9 448
Ahmad A. Attallah United States 13 188 0.7× 56 0.3× 111 1.1× 47 1.0× 9 0.2× 26 386
Helen Stead United Kingdom 6 506 1.8× 120 0.7× 54 0.5× 12 0.2× 98 2.5× 8 631

Countries citing papers authored by Tai‐Juan Aw

Since Specialization
Citations

This map shows the geographic impact of Tai‐Juan Aw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tai‐Juan Aw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tai‐Juan Aw more than expected).

Fields of papers citing papers by Tai‐Juan Aw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tai‐Juan Aw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tai‐Juan Aw. The network helps show where Tai‐Juan Aw may publish in the future.

Co-authorship network of co-authors of Tai‐Juan Aw

This figure shows the co-authorship network connecting the top 25 collaborators of Tai‐Juan Aw. A scholar is included among the top collaborators of Tai‐Juan Aw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tai‐Juan Aw. Tai‐Juan Aw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
McKenna, Michael J., Aaron C. Petersen, Simon Sostaric, et al.. (2024). Digoxin and exercise effects on skeletal muscle Na+,K+‐ATPase isoform gene expression in healthy humans. Experimental Physiology. 109(11). 1909–1921. 1 indexed citations
2.
Sostaric, Simon, Aaron C. Petersen, Craig A. Goodman, et al.. (2022). Oral digoxin effects on exercise performance, K+ regulation and skeletal muscle Na+,K+‐ATPase in healthy humans. The Journal of Physiology. 600(16). 3749–3774. 4 indexed citations
3.
Chan, Clara C., Christopher M. Reid, Tai‐Juan Aw, et al.. (2009). Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis. Journal of Hypertension. 27(12). 2332–2341. 87 indexed citations
4.
Krum, Henry, Tai‐Juan Aw, Danny Liew, & Steven Joseph Haas. (2006). Blood Pressure Effects of COX-2 Inhibitors. Journal of Cardiovascular Pharmacology. 47(Supplement 1). S43–S48. 14 indexed citations
5.
Aw, Tai‐Juan, Danny Liew, Geoffrey H. Tofler, et al.. (2006). Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?. Journal of Hypertension. 24(10). 1979–1984. 8 indexed citations
6.
Aw, Tai‐Juan, Steven Joseph Haas, Danny Liew, & Henry Krum. (2005). Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure. Archives of Internal Medicine. 165(5). 490–490. 256 indexed citations
7.
Aw, Tai‐Juan, Steven Joseph Haas, Danny Liew, & Henry Krum. (2005). Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure. ACC Current Journal Review. 14(6). 5–5. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026